15
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Validation of Fourier Transform Infrared Spectroscopy for Serotyping of Streptococcus pneumoniae

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          ABSTRACT

          Fourier transform infrared (FT-IR) spectroscopy (IR Biotyper; Bruker) allows highly discriminatory fingerprinting of closely related bacterial strains. In this study, FT-IR spectroscopy-based capsular typing of Streptococcus pneumoniae was validated as a rapid, cost-effective, and medium-throughput alternative to the classical phenotypic techniques. A training set of 233 strains was defined, comprising 34 different serotypes and including all 24 vaccine types (VTs) and 10 non-vaccine types (NVTs). The acquired spectra were used to (i) create a dendrogram where strains clustered together according to their serotypes and (ii) train an artificial neural network (ANN) model to predict unknown pneumococcal serotypes. During validation using 153 additional strains, we reached 98.0% accuracy for determining serotypes represented in the training set. Next, the performance of the IR Biotyper was assessed using 124 strains representing 59 non-training set serotypes. In this setting, 42 of 59 serotypes (71.1%) could be accurately categorized as being non-training set serotypes. Furthermore, it was observed that comparability of spectra was affected by the source of the Columbia medium used to grow the pneumococci and that this complicated the robustness and standardization potential of FT-IR spectroscopy. A rigorous laboratory workflow in combination with specific ANN models that account for environmental noise parameters can be applied to overcome this issue in the near future. The IR Biotyper has the potential to be used as a fast, cost-effective, and accurate phenotypic serotyping tool for S. pneumoniae.

          Related collections

          Most cited references75

          • Record: found
          • Abstract: found
          • Article: not found

          Streptococcus pneumoniae: transmission, colonization and invasion

          Streptococcus pneumoniae as a complex relationship with its obligate human host. On the one hand, the pneumococci are highly adapted commensals, and their main reservoir on the mucosal surface of the upper airways of carriers enables transmission. On the other hand, they can cause severe disease when bacterial and host factors allow them to invade essentially sterile sites, such as the middle ear spaces, lungs, bloodstream and meninges. Transmission, colonization and invasion depend on the remarkable ability of S. pneumoniae to evade or take advantage of the host inflammatory and immune responses. The different stages of pneumococcal carriage and disease have been investigated in detail in animal models and, more recently, in experimental human infection. Furthermore, widespread vaccination and the resulting immune pressure have shed light on pneumococcal population dynamics and pathogenesis. Here, we review the mechanistic insights provided by these studies on the multiple and varied interactions of the pneumococcus and its host.
            Bookmark
            • Record: found
            • Abstract: not found
            • Book: not found

            PAST: Paleontological Statistics Software Package for Education and Data Analysis

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study.

              The seven-valent pneumococcal conjugate vaccine (PCV7) has reduced vaccine-type (VT) invasive pneumococcal disease but increases in non-vaccine-type (NVT) disease have varied between countries. We assess the effect of the PCV7 vaccination on VT and NVT disease in England and Wales. The study cohort was the population of England and Wales from July, 2000, to June, 2010. We calculated incidence rate ratios (IRRs) to compare incidences of VT and NVT disease before (2000-06) and after (2009-10) the introduction of PCV7. We used data from the national surveillance database. Cases included in our analysis were restricted to those confirmed by culture linked with isolates referred for serotyping at the national reference centre by laboratories in England and Wales. We adjusted for potential bias from missing data (serotype and age of patient) and changes in case ascertainment rates during the study period. 5809 cases of invasive pneumococcal disease were reported in 2009-10, giving an incidence of 10·6 per 100,000 population in 2009-10, which, when compared with the adjusted average annual incidence of 16·1 in 2000-06, gives an overall reduction of 34% (95% CI 28-39). VT disease decreased in all age groups, with reductions of 98% in individuals younger than 2 years and 81% in those aged 65 years or older. NVT disease increased by 68% in individuals younger than 2 years and 48% in those aged 65 years or older, giving an overall reduction in invasive pneumococcal disease of 56% in those younger than 2 years and 19% in those aged 65 years or older. After vaccine introduction, more NVT serotypes increased in frequency than decreased, which is consistent with vaccine-induced replacement. Key serotypes showing replacement were 7F, 19A, and 22F. Increases in NVT invasive pneumococcal disease were not associated with antimicrobial resistance. Despite much serotype replacement, a substantial reduction in invasive pneumococcal disease in young children can be achieved with PCV7 vaccination, with some indirect benefit in older age groups. Further reductions should be achievable by use of higher valency vaccines. Robust surveillance data are needed to properly assess the epidemiological effect of multivalent pneumococcal disease vaccines. Health Protection Agency. Copyright © 2011 Elsevier Ltd. All rights reserved.
                Bookmark

                Author and article information

                Contributors
                Role: Editor
                Journal
                J Clin Microbiol
                J Clin Microbiol
                JCM
                Journal of Clinical Microbiology
                American Society for Microbiology (1752 N St., N.W., Washington, DC )
                0095-1137
                1098-660X
                14 June 2022
                July 2022
                14 June 2022
                : 60
                : 7
                : e00325-22
                Affiliations
                [a ] Bacterial Diseases Unit, Sciensano, Brussels, Belgium
                [b ] Bruker Daltonic GmbH, Bremen, Germany
                [c ] Department of Infectious Diseases, Microbiology and Hygiene, University Hospital of Heidelberg, Heidelberg, Germany
                [d ] Department of Medical Microbiology and Infection Prevention, UMC Amsterdam, University of Amsterdam, Amsterdam, The Netherlands
                [e ] Netherlands Reference Laboratory for Bacterial Meningitis, UMC Amsterdam, University of Amsterdam, Amsterdam, The Netherlands
                [f ] Department of Bacteria, Parasites and Fungi, Statens Serum Institutgrid.6203.7, , Copenhagen, Denmark
                [g ] National Reference Centre for (invasive) S. pneumoniae, UZ Leuven, Leuven, Belgium
                [h ] Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium
                Johns Hopkins
                Author notes

                The authors declare a conflict of interest. N.M. and M.K. are employees of Bruker Daltonics.

                Author information
                https://orcid.org/0000-0003-1649-2153
                https://orcid.org/0000-0001-5601-7934
                https://orcid.org/0000-0002-4338-1929
                Article
                00325-22 jcm.00325-22
                10.1128/jcm.00325-22
                9297836
                35699436
                d7c801b0-681c-4ad6-b388-e46223270565
                Copyright © 2022 Passaris et al.

                This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.

                History
                : 28 February 2022
                : 1 April 2022
                : 24 May 2022
                Page count
                Figures: 5, Tables: 2, Equations: 0, References: 75, Pages: 16, Words: 10634
                Categories
                Bacteriology
                bacteriology, Bacteriology
                Custom metadata
                July 2022

                Microbiology & Virology
                ft-ir spectroscopy,streptococcus pneumoniae,machine learning,pneumococcus,serotyping

                Comments

                Comment on this article